GlassScriptPhysician profile
Smitha V Shenoy
NPI 1598971418
$1,475.89
in general payments reported to CMS, 2019-2025
22 companies · $259 in 2025
The $259 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $448 · 2023: $383 · 2024: $108 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $231.87 | 2024-2025 | Prialt |
| Amgen INC. | $191.02 | 2022-2023 | Aimovig |
| Emd Serono, INC. | $147.14 | 2022-2023 | Mavenclad |
| Avanos Medical | $134.83 | 2021 | |
| Acacia Pharma INC | $120.16 | 2021 | |
| Collegium Pharmaceutical, INC. | $98.74 | 2024-2025 | Xtampza |
| Lilly USA, LLC | $83.06 | 2022-2023 | Emgality, Reyvow |
| Lundbeck LLC | $74.13 | 2022-2023 | Vyepti |
| Biogen, INC. | $47.72 | 2022 | |
| Merz Pharmaceuticals, LLC | $38.80 | 2023 | Xeomin |
| Harmony Biosciences LLC | $37.16 | 2023 | Wakix |
| Axsome Therapeutics, INC. | $36.75 | 2023 | Sunosi |
| Ipsen Biopharmaceuticals, INC | $36.40 | 2022 | |
| Redhill Biopharma INC. | $32.34 | 2022 | |
| Abbvie INC. | $28.63 | 2023 | Rinvoq |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $26.63 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.25 | 2023 | Soliris |
| Baudax Bio INC. | $22.22 | 2021 | |
| Scilex Pharmaceuticals INC. | $19.27 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $17.69 | 2024 | |
| Merck Sharp & Dohme LLC | $15.18 | 2023 | Bridion |
| Arbor Pharmaceuticals, INC. | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smitha Shenoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.